Nanomedicine News

RSS

Cell Stays Alive with Nanoscale Film Coating

Some bacteria form endospores on cell walls to protect their DNA in case of nutrient deficiency. When an endospore meets a suitable environment for survival, the cell can revert to the original state from which it can reproduce.

27 Nov 2014

BSI Awards ISO 13485:2003 Certification to Nanomix

Nanomix Inc., a leading nanotechnology company focused on the development of mobile diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings, today announced it has received International Standards Organization (ISO) 13485:2003 certification. The certification was awarded by the British Standards Institution (BSI), one of the world's leading certification bodies.

From Nanomix Inc 26 Nov 2014

New Hybrid Vehicle for Delivery of Genetically Engineered DNA Vaccines

A new hybrid vehicle is under development.
Its performance isn’t measured by the distance it travels, but rather the delivery of its cargo: vaccines that contain genetically engineered DNA to fight HIV, cancer, influenza and other maladies.

26 Nov 2014

Magnetic Nanoparticles Coated with Targeting Proteins Can Stimulate Stem Cells to Regenerate Bone

Researchers in bone tissue regeneration believe they have made a significant breakthrough for sufferers of bone trauma, disease or defects such as osteoporosis.

25 Nov 2014

Iron-Oxide Based Nanoparticles Destroy Cancer Cells Using Photo-Thermal Therapy

Conventional treatment seeks to eradicate cancer cells by drugs and therapy delivered from outside the cell, which may also affect (and potentially harm) nearby normal cells.

25 Nov 2014

New Multiple Drug Eluting Vaginal Ring from Particle Sciences

Particle Sciences, Inc (PSI), the leading CDMO for drug eluting devices, has developed and manufactured a new innovative vaginal ring for Ladee Pharma Research Institute (LPRI), the Research and Development arm of Exeltis Pharmaceuticals.

From Particle Sciences 24 Nov 2014

Merrimack Presents Phase 1 Results from Ferumoxytol Iron Oxide Nanoparticle Study at 26th EORTC-NCI-AACR Symposium

Merrimack Pharmaceuticals, Inc. today announced data from multiple presentations at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Therapeutics. Data presented includes the first public presentation on the preclinical activity and potency of MM-131, and preclinical and clinical data on MM-151.

24 Nov 2014

Novavax' Nanoparticle Vaccine for Infant Protection via Maternal Immunization Granted FDA Fast Track Designation

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Novavax' RSV F-Protein nanoparticle vaccine candidate (RSV F vaccine) for protection of infants via maternal immunization.

From Novavax Inc. 24 Nov 2014

Nanophosphor Biomarker Lights Up On Detecting Tumour Cells

Nanyang Technological University (NTU) has invented a unique biomarker with two exceptional functions.

24 Nov 2014

Iron-Oxide Nanoparticles Can Successfully Detect Ovarian Tumors In Vivo

Google’s latest search initiative isn’t taking place online, but in the human body instead. On October 28, The Wall Street Journal reported that the Internet giant wants to design tiny magnetic particles to patrol the body for signs of cancer and other diseases. Google said its nanoparticles, less than one-thousandth the width of a red blood cell, would seek out and attach themselves to cells, proteins or other molecules inside the body.

From Manhattan Scientifics Inc. 24 Nov 2014